About Index Trending news
Analyze
Top 50 Pricing
Vaximm

Vaximm

Vaximm

Vaximm, a vaccine company based in Switzerland developing immunotherapies for cancer patients, offers VXM01 targeting tumor vasculature.

Elsewhere

Alexa global traffic share

12 Jan 2011
$8,000,000
Venture capital